In South San Francisco, Genentech showed that recombinant DNA technology could transform medicine and create therapies once ...

The Investment Committee give you their top stocks to watch for the second half.

Nearly 1 million bottles of the medication are being recalled because they may contain a foreign substance, according to an ...

The FDA reports state the recalls affect more than 944,000 bottles of the medications.

By Jonathan Stempel July 1 (Reuters) - A federal judge on Wednesday blocked Colorado from capping the price of Amgen's ...

Amgen (AMGN) closed at $366.44 in the latest trading session, marking a -2.06% move from the prior day. The stock's change was less than the S&P 500's daily gain of 0.72%. Elsewhere, the Dow gained 0.

Amgen has issued a voluntary recall for nearly 1 million bottles of the heart medication Corlanor (ivabradine) due to possible contamination. The nationwide recall was issued by the company on June 4 ...

A U.S. Centers for Medicare & Medicaid Services 18-month ​trial program will offer for the first time Novo Nordisk’s Wegovy ...

If you are wondering whether Amgen stock still offers value at current levels, this article walks through what the numbers ...

By Puyaan Singh June 29 (Reuters) - The New England Journal of Medicine on Monday retracted an article on a pivotal clinical ...

Viridian Therapeutics has scored an FDA approval for Lumvoa to treat thyroid eye disease (TED), triggering competition with ...

Amgen (AMGN) stock is in focus as an expert panel of the European Medicines Agency recommends withdrawal of the company's ...